These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 26518624)

  • 1. Sialic acids in cancer biology and immunity.
    Pearce OM; Läubli H
    Glycobiology; 2016 Feb; 26(2):111-28. PubMed ID: 26518624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology.
    Hugonnet M; Singh P; Haas Q; von Gunten S
    Front Immunol; 2021; 12():799861. PubMed ID: 34975914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a sialate-O-acetylesterase (NanS) from the oral pathogen Tannerella forsythia that enhances sialic acid release by NanH, its cognate sialidase.
    Phansopa C; Kozak RP; Liew LP; Frey AM; Farmilo T; Parker JL; Kelly DJ; Emery RJ; Thomson RI; Royle L; Gardner RA; Spencer DI; Stafford GP
    Biochem J; 2015 Dec; 472(2):157-67. PubMed ID: 26378150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer.
    Adams OJ; Stanczak MA; von Gunten S; Läubli H
    Glycobiology; 2018 Sep; 28(9):640-647. PubMed ID: 29309569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.
    Khatua B; Roy S; Mandal C
    Indian J Med Res; 2013 Nov; 138(5):648-62. PubMed ID: 24434319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs.
    Angata T
    Front Immunol; 2018; 9():2885. PubMed ID: 30564250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are humans prone to autoimmunity? Implications from evolutionary changes in hominin sialic acid biology.
    Varki A
    J Autoimmun; 2017 Sep; 83():134-142. PubMed ID: 28755952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2.
    Wieboldt R; Sandholzer M; Carlini E; Lin CW; Börsch A; Zingg A; Lardinois D; Herzig P; Don L; Zippelius A; Läubli H; Mantuano NR
    Cell Mol Immunol; 2024 May; 21(5):495-509. PubMed ID: 38448555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions.
    Lübbers J; Rodríguez E; van Kooyk Y
    Front Immunol; 2018; 9():2807. PubMed ID: 30581432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Functions and Analytical Strategies of Sialic Acids in Tumor.
    Zhou X; Yang G; Guan F
    Cells; 2020 Jan; 9(2):. PubMed ID: 31979120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis.
    Büll C; Heise T; Adema GJ; Boltje TJ
    Trends Biochem Sci; 2016 Jun; 41(6):519-531. PubMed ID: 27085506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7.
    van Houtum EJH; Kers-Rebel ED; Looman MW; Hooijberg E; Büll C; Granado D; Cornelissen LAM; Adema GJ
    Cell Mol Life Sci; 2023 May; 80(6):169. PubMed ID: 37253806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional evaluation of activation-dependent alterations in the sialoglycan composition of T cells.
    Naito-Matsui Y; Takada S; Kano Y; Iyoda T; Sugai M; Shimizu A; Inaba K; Nitschke L; Tsubata T; Oka S; Kozutsumi Y; Takematsu H
    J Biol Chem; 2014 Jan; 289(3):1564-79. PubMed ID: 24297165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wild and domestic animals variably display Neu5Ac and Neu5Gc sialic acids.
    Nemanichvili N; Spruit CM; Berends AJ; Gröne A; Rijks JM; Verheije MH; de Vries RP
    Glycobiology; 2022 Aug; 32(9):791-802. PubMed ID: 35648131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells.
    Nguyen DH; Tangvoranuntakul P; Varki A
    J Immunol; 2005 Jul; 175(1):228-36. PubMed ID: 15972653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.
    Rodrigues E; Macauley MS
    Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29912148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sweet escape: sialic acids in tumor immune evasion.
    Büll C; den Brok MH; Adema GJ
    Biochim Biophys Acta; 2014 Aug; 1846(1):238-46. PubMed ID: 25026312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of sialic acids in the immune recognition of xenografts.
    French BM; Sendil S; Pierson RN; Azimzadeh AM
    Xenotransplantation; 2017 Nov; 24(6):. PubMed ID: 29057592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity.
    Bärenwaldt A; Läubli H
    Expert Opin Ther Targets; 2019 Oct; 23(10):839-853. PubMed ID: 31524529
    [No Abstract]   [Full Text] [Related]  

  • 20. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
    van de Wall S; Santegoets KCM; van Houtum EJH; Büll C; Adema GJ
    Trends Immunol; 2020 Apr; 41(4):274-285. PubMed ID: 32139317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.